|
1
|
Banz Y and Rieben R: Role of complement
and perspectives for intervention in ischemia-reperfusion damage.
Ann Med. 44:205–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Granger DN: Ischemia-reperfusion:
Mechanisms of microvascular dysfunction and the influence of risk
factors for cardiovascular disease. Microcirculation. 6:167–178.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev
Cell Mol Biol. 298:229–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carden DL and Granger DN: Pathophysiology
of ischaemia-reperfusion injury. J Pathol. 190:255–266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J
and Ai K: Reactive oxygen species-based nanomaterials for the
treatment of myocardial ischemia reperfusion injuries. Bioact
Mater. 7:47–72. 2021.PubMed/NCBI
|
|
6
|
Linfert D, Chowdhry T and Rabb H:
Lymphocytes and ischemia-reperfusion injury. Transplant Rev
(Orlando). 23:1–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Safari S, Motavaf M, Seyed Siamdoust SA
and Alavian SM: Hepatotoxicity of halogenated inhalational
anesthetics. Iran Red Crescent Med J. 16:e201532014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu R, Ishibe Y and Ueda M:
Isoflurane-sevoflurane administration before ischemia attenuates
ischemia-reperfusion-induced injury in isolated rat lungs.
Anesthesiology. 92:833–840. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herrero de la Parte B, Roa-Esparza J,
Cearra I, Ruiz Montesinos I, Alonso-Alconada D, Alonso-Varona A,
Mar Medina C, Iturrizaga Correcher S and García-Alonso I: The
prevention of ischemia-reperfusion injury in elderly rats after
lower limb tourniquet use. Antioxidants (Basel). 11:19362022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harkin DW, Barros D'Sa AA, McCallion K,
Hoper M and Campbell FC: Ischemic preconditioning before lower limb
ischemia-reperfusion protects against acute lung injury. J Vasc
Surg. 35:1264–1273. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lucchinetti E, Ambrosio S, Aguirre J,
Herrmann P, Härter L, Keel M, Meier T and Zaugg M: Sevoflurane
inhalation at sedative concentrations provides endothelial
protection against ischemia-reperfusion injury in humans.
Anesthesiology. 106:262–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chappell D, Heindl B, Jacob M, Annecke T,
Chen C, Rehm M, Conzen P and Becker BF: Sevoflurane reduces
leukocyte and platelet adhesion after ischemia-reperfusion by
protecting the endothelial glycocalyx. Anesthesiology. 115:483–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Percie du Sert N, Hurst V, Ahluwalia A,
Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl
U, et al: The ARRIVE guidelines 2.0: Updated guidelines for
reporting animal research. Exp Physiol. 105:1459–1466. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Research Council (US), .
Committee for the Update of the Guide for the Care and Use of
Laboratory Animals: Guide for the care and use of laboratory
animals. 8th edition. National Academies Press; Washington, DC:
2011
|
|
15
|
Yesil S, Ozdemir C, Arslan M, Gundogdu AC,
Kavutcu M and Atan A: Protective effect of cerium oxide on
testicular function and oxidative stress after torsion/detorsion in
adult male rats. Exp Ther Med. 25:12022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Conzen PF, Vollmar B, Habazettl H, Frink
EJ, Peter K and Messmer K: Systemic and regional hemodynamics of
isoflurane and sevoflurane in rats. Anesth Analg. 74:79–88. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Namdar F, Bahrami F, Bahari Z, Ghanbari B,
Elahi SA and Mohammadi MT: Evaluation of the effects of fullerene
C60 nanoparticles on oxidative stress parameters in normal rats
liver and brain. J Adv Med Biomed Res. 27:8–15. 2019. View Article : Google Scholar
|
|
18
|
Tüfek H and Özcan Ö: 4R rule in laboratory
animal science. Comm J Biol. 2:55–60. 2018. View Article : Google Scholar
|
|
19
|
Sivgin V, Yalcin G, Kucuk A, Sezen SC,
Afandiyeva N and Arslan M: Effects of fullerenol nanoparticles on
kidney tissue in sevoflurane-treated rats. Bratisl Lek Listy.
121:117–121. 2020.PubMed/NCBI
|
|
20
|
Ozdemirkan A, Kurtipek AC, Kucuk A,
Ozdemir C, Yesil S, Sezen SC, Kavutcu M and Arslan M: Effect of
cerium oxide on kidney and lung tissue in rats with testicular
torsion/detorsion. Biomed Res Int. 2022:31764552022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kartal S, Kip G, Küçük A, Atan A, Erdem Ö
and Kavutçu M: The efficacy of dexmedetomidine on lung injury
induced by renal ischemia/reperfusion in diabetic rats. Anaesth.
pain intensive care. 24:272–277. 2020.
|
|
22
|
Van Ye TM, Roza AM, Pieper GM, Henderson J
Jr, Johnson CP and Adams MB: Inhibition of intestinal lipid
peroxidation does not minimize morphological damage. J Surg Res.
55:553–558. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aebi H: Catalase. Methods of Enzymatic
Analysis. Bergmeyer HU: Academic Press; London: pp. 673–677. 1974,
View Article : Google Scholar
|
|
24
|
Habig WH, Pabst MJ and Jakoby WB:
Glutathione S-transferases. The first enzymatic step in mercapturic
acid formation. J Biol Chem. 249:7130–7139. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lowry OH, Rosenbraugh NJ, Farr AL and
Randall RJ: Protein measurement with folin phenol reagent. J Biol
Chem. 193:265–275. 1951. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Garbaisz D, Turoczi Z, Aranyi P, Fulop A,
Rosero O, Hermesz E, Ferencz A, Lotz G, Harsanyi L and Szijarto A:
Attenuation of skeletal muscle and renal injury to the lower limb
following ischemia-reperfusion using mPTP inhibitor NIM-811. PLoS
One. 9:e1010672014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shih JM, Shih YM, Hou YC, Pai MH, Yeh CL
and Yeh SL: Effects of fish oil-based lipid emulsion on
inflammation and kidney injury in mice subjected to unilateral hind
limb ischemia/reperfusion. Cytokine. 111:49–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matute-Bello G, Downey G, Moore BB,
Groshong SD, Matthay MA, Slutsky AS and Kuebler WM; Acute Lung
Injury in Animals Study Group, : An Official American Thoracic
Society Workshop Report: Features and Measurements of Experimental
Acute Lung Injury in Animals. Am J Respir Cell Mol Biol.
44:725–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huwae TECJ, Santoso ARB, Kesuma W, Sujuti
H, Ratnawati R, Sukmajaya WP and Hidayat M: Reperfusion interval as
a prevention of lung injury due to limb ischemia-Reperfusion after
application of tourniquet in murine experimental study. Indian J
Orthop. 54:704–710. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang C, Zhang L, Shi Y, Yi H, Zhao Y,
Chen J, Pollock CA and Chen XM: The KCa3. 1 blocker TRAM34 reverses
renal damage in a mouse model of established diabetic nephropathy.
PLoS One. 13:e01928002018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen M, Ai G, Zhou J, Mao W, Li H and Guo
J: circMTO1 promotes tumorigenesis and chemoresistance of cervical
cancer via regulating miR-6893. Biomed Pharmacother.
117:1090642019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vlastos D, Zeinah M, Ninkovic-Hall G,
Vlachos S, Salem A, Asonitis A, Chavan H, Kalampalikis L, Al
Shammari A, Alvarez Gallesio JM, et al: The effects of ischaemic
conditioning on lung ischaemia-reperfusion injury. Respir Res.
23:3512022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Woodruff TM, Arumugam TV, Shiels IA, Reid
RC, Fairlie DP and Taylor SM: Protective effects of a potent C5a
receptor antagonist on experimental acute limb ischemia-reperfusion
in rats. J Surg Res. 116:81–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schofield ZV, Woodruff TM, Halai R, Wu MC
and Cooper MA: Neutrophils-a key component of ischemia-reperfusion
injury. Shock. 40:463–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yassin MM, Harkin DW, Barros D'Sa AA,
Halliday MI and Rowlands BJ: Lower limb ischemia-reperfusion injury
triggers a systemic inflammatory response and multiple organ
dysfunction. World J Surg. 26:115–121. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee HT, Ota-Setlik A, Fu Y, Nasr SH and
Emala CW: Differential protective effects of volatile anesthetics
against renal ischemia-reperfusion injury in vivo. Anesthesiology.
101:1313–1324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee HT, Kim M, Jan M and Emala CW:
Anti-inflammatory and antinecrotic effects of the volatile
anesthetic sevoflurane in kidney proximal tubule cells. Am J
Physiol Renal Physiol. 291:F67–F78. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Hert SG, Van der Linden PJ, Cromheecke
S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG,
Stockman BA and Rodrigus IE: Cardioprotective properties of
sevoflurane in patients undergoing coronary surgery with
cardiopulmonary bypass are related to the modalities of its
administration. Anesthesiology. 101:299–310. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu P, Zhang J, Yu S, Luo Z, Hua F, Yuan L,
Zhou Z, Liu Q, Du X, Chen S, et al: Protective effect of
sevoflurane postconditioning against cardiac ischemia/reperfusion
injury via ameliorating mitochondrial impairment, oxidative stress
and rescuing autophagic clearance. PLoS One. 10:e01346662015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu G, Wang X, Xiong Y, Ma X and Qu L:
Effect of sevoflurane pretreatment in relieving liver
ischemia/reperfusion-induced pulmonary and hepatic injury. Acta Cir
Bras. 34:e2019008052019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Higuchi H, Sumita S, Wada H, Ura T,
Ikemoto T, Nakai T, Kanno M and Satoh T: Effects of sevoflurane and
isoflurane on renal function and on possible markers of
nephrotoxicity. Anesthesiology. 89:307–322. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Davıd WIF, Ibberson RM, Dennıs TJS, Hare
JP and Prassıdes K: Structural phase transitions in the fullerene
C60. Europhy Lett. 18:735–736. 1992. View Article : Google Scholar
|
|
43
|
Chen YW, Hwang KC, Yen CC and Lai YL:
Fullerene derivatives protect against oxidative stress in RAW 264.7
cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp
Physiol. 287:R21–R26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Djordjević A, Bogdanović G and Dobrić S:
Fullerenes in biomedicine. J BUON. 11:391–404. 2006.PubMed/NCBI
|
|
45
|
Harhaji L, Isakovic A, Raicevic N,
Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S,
Markovic I and Trajkovic V: Multiple mechanisms underlying the
anticancer action of nanocrystalline fullerene. Eur J Pharmacol.
568:89–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chien CT, Chen CF, Hsu SM, Chiang LY and
Lai MK: Forced expression of bcl-2 and bcl-xL by novel
water-soluble fullerene, C60 (glucosamine) 6, reduces renal
ischemia/reperfusion-induced oxidative stress. Fullerene Sci
Technol. 9:77–88. 2007. View Article : Google Scholar
|
|
47
|
Chien CT, Lee PH, Chen CF, Ma MC, Lai MK
and Hsu SM: De novo demonstration and co-localization of
free-radical production and apoptosis formation in rat kidney
subjected to ischemia/reperfusion. J Am Soc Nephrol. 12:973–982.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nozdrenko DN, Prylutskyy YI, Ritter U and
Scharff P: Protective effect of water-soluble pristine C 60
fullerene in ischemia-reperfusion injury of skeletal muscle. Int J
Phys Pathophysiol. 5:97–104. 2014. View Article : Google Scholar
|
|
49
|
Chien CT, Chen CF, Chiang LY and Lai MK:
Novel water-soluble hexa (sulfobutyl) fullerene attenuates
apoptosis formation after ischemic renal failure. Fullerene Sci
Technol. 7:529–540. 1999. View Article : Google Scholar
|
|
50
|
Monteiro-Riviere NA, Linder KE, Inman AO,
Saathoff JG, Xia XR and Riviere JE: Lack of hydroxylated fullerene
toxicity after intravenous administration to female Sprague-Dawley
rats. J Toxicol Environ Health A. 75:367–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gueler F, Gwinner W, Schwarz A and Haller
H: Long-term effects of acute ischemia and reperfusion injury.
Kidney Int. 66:523–527. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zang X, Zhou J, Zhang X, Han Y and Chen X:
Ischemia reperfusion injury: Opportunities for nanoparticles. ACS
Biomater Sci Eng. 6:6528–6539. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Trujillo-Rangel WÁ, García-Valdés L,
Méndez-Del Villar M, Castañeda-Arellano R, Totsuka-Sutto SE and
García-Benavides L: Therapeutic targets for regulating oxidative
damage induced by ischemia-reperfusion injury: A study from a
pharmacological perspective. Oxid Med Cell Longev.
2022:86243182022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou L, Tang S, Li F, Wu Y, Li S, Cui L,
Luo J, Yang L, Ren Z, Zhang J, et al: Ceria nanoparticles
prophylactic used for renal ischemia-reperfusion injury treatment
by attenuating oxidative stress and inflammatory response.
Biomaterials. 287:1216862022. View Article : Google Scholar : PubMed/NCBI
|
